Table 1.
Baseline characteristics of two groups
| Baseline characteristics | Control TAVI group (n = 101) | Third degree AV block‐TAVI (+) (n = 49) | p Value |
|---|---|---|---|
| Age (mean) | 80.36 ± 8.7 | 81.84 ± 7.0 | .3 |
| Male/female | 74/27 | 35/14 | .5 |
| Hypertension | 83 (82%) | 35 (70%) | .28 |
| Diabetes mellitus | 36 (35%) | 16 (32%) | .4 |
| Hyperlipidemia | 21 (20%) | 4 (8%) | .09 |
| Coronary artery disease | 38 (37%) | 30 (60%) | <.05 |
| Smoke | 38 (37%) | 13 (26%) | .6 |
| Peripheral vascular disease | 2 (2%) | 5 (10%) | .2 |
| Previous cerebrovascular event | 7 (6%) | 2 (4%) | .3 |
| COPD | 20 (19%) | 13 (26%) | .7 |
| LVEF (mean %) | 53.10 ± 12.1 | 51.69 ± 13.8 | .5 |
| GFR (ml min−1 1.73 m−2) | 53.95 ± 20.1 | 54.39 ± 21.8 | .9 |
| Pulmonary artery pressure (mm Hg) | 36.64 ± 12.1 | 44.33 ± 16.3 | .8 |
| Logistic EuroSCORE (mean ± SD) % | 21.5 ± 2.8 | 20.9 ± 3.3 | .1 |
| STS score (mean ± SD) % | 10.0 ± 3.5 | 9.9 ± 4.2 | .7 |
Abbreviations: COPD, chronic obstructive pulmonary disease, GFR, glomerular filtration rate, LVEF, left ventricle ejection fraction.